ATENOLOL AND PROPRANOLOL IN NEUROLEPTIC-INDUCED AKATHISIA

被引:19
|
作者
REITER, S [1 ]
ADLER, L [1 ]
ANGRIST, B [1 ]
CORWIN, J [1 ]
ROTROSEN, J [1 ]
机构
[1] NYU,VET ADM MED CTR,SCH MED,DEPT PSYCHIAT,PSYCHIAT SERV,NEW YORK,NY 10003
关键词
D O I
10.1097/00004714-198708000-00034
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:279 / 280
页数:2
相关论文
共 50 条
  • [21] SUCCESSFUL PROPRANOLOL THERAPY FOR NEUROLEPTIC-INDUCED AKATHISIA RESISTANT TO ANTICHOLINERGIC AND BENZODIAZEPINE DRUGS
    HERMESH, H
    MOLCHO, A
    MUNITZ, H
    CLINICAL NEUROPHARMACOLOGY, 1988, 11 (04) : 369 - 372
  • [22] NEUROLEPTIC-INDUCED AKATHISIA TREATED WITH PINDOLOL
    REITER, S
    ADLER, L
    ERLE, S
    DUNCAN, E
    AMERICAN JOURNAL OF PSYCHIATRY, 1987, 144 (03): : 383 - 384
  • [23] OPIOID RESPONSIVENESS OF NEUROLEPTIC-INDUCED AKATHISIA
    WALTERS, A
    HENING, W
    CHOKROVERTY, S
    FAHN, S
    ANNALS OF NEUROLOGY, 1985, 18 (01) : 137 - 137
  • [24] EFFICACY OF BETAXOLOL IN NEUROLEPTIC-INDUCED AKATHISIA
    ADLER, LA
    ANGRIST, B
    ROTROSEN, J
    PSYCHIATRY RESEARCH, 1991, 39 (02) : 193 - 198
  • [25] THE PHARMACOLOGIC TREATMENT OF NEUROLEPTIC-INDUCED AKATHISIA
    FLEISCHHACKER, WW
    ROTH, SD
    KANE, JM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1990, 10 (01) : 12 - 21
  • [27] ACTIVATION TASKS IN NEUROLEPTIC-INDUCED AKATHISIA
    FLEISCHHACKER, WW
    MILLER, CH
    BARNAS, C
    SCHETT, P
    BERGMANN, K
    PEROVICH, R
    ALVIR, JMA
    LIEBERMAN, JA
    KANE, JM
    SCHIZOPHRENIA RESEARCH, 1991, 4 (03) : 363 - 363
  • [28] CYPROHEPTADINE TREATMENT IN NEUROLEPTIC-INDUCED AKATHISIA
    WEISS, D
    AIZENBERG, D
    HERMESH, H
    ZEMISHLANY, Z
    MUNITZ, H
    RADWAN, M
    WEIZMAN, A
    BRITISH JOURNAL OF PSYCHIATRY, 1995, 167 : 483 - 486
  • [29] SULCAL SIZE AND NEUROLEPTIC-INDUCED AKATHISIA
    SANDYK, R
    KAY, SR
    BIOLOGICAL PSYCHIATRY, 1990, 27 (04) : 466 - 467
  • [30] POLYSOMNOGRAPHIC CHARACTERISTICS OF NEUROLEPTIC-INDUCED AKATHISIA
    LIPINSKI, JF
    HUDSON, JI
    CUNNINGHAM, SL
    AIZLEY, HG
    KECK, PE
    MALLYA, G
    ARANOW, RB
    LUKAS, SE
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (05) : 413 - 419